|
CIL, Nexomics Biosciences enter supply agreement to offer isotope-labeled ... - Pharmaceutical Business Review
<img alt="" height="1" width="1" /> CIL, Nexomics Biosciences enter supply agreement to offer isotope-labeled ... Pharmaceutical Business Review Cambridge Isotope Laboratories CEO Joel Bradley said Nexomics' success in developing techniques to determine protein structure using Nuclear Magnetic Resonance (NMR) spectroscopy nicely complements the company's mission to offer isotope enriched ... CIL, Nexomics Biosciences enter supply agreement to offer isotope-labeled ... - Pharmaceutical Business Review More... |
| All times are GMT. The time now is 05:28 AM. |
Powered by vBulletin® Version 3.7.3
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Search Engine Friendly URLs by vBSEO 3.6.0
Copyright, BioNMR.com, 2003-2013